Govaerts, LaurenzGeldof, TineSimoens, StevenHuys, Isabelle2018-01-232018-01-2320171098-301510.1016/j.jval.2017.08.1586http://hdl.handle.net/20.500.12127/5898New co-development approaches in personalized medicine challenge current decisional frameworks of health-technology access and reimbursement procedures. We aim to conceptualize an efficient typology-based decisional framework which takes into account the development and market access synchronism between therapeutic (Tx) and diagnostic (Dx) components of personalized medicines.enHealthcareClinical PharmacologyPharmacotherapyA typology-based decisional framework to support market access and reimbursement decisions for personalised medicinesValue in Health. The Journal of the International Society for Pharmacoeconomics and Outcomes Research1524-473317658131183